Edition:
United Kingdom

Axsome Therapeutics Inc (AXSM.OQ)

AXSM.OQ on NASDAQ Stock Exchange Global Market

15.12USD
22 Apr 2019
Change (% chg)

-- (--)
Prev Close
$15.12
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
430,935
52-wk High
$16.80
52-wk Low
$1.94

About

Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders, including pain. It operates in the business of developing novel therapies for the management of CNS disorders segment. Its product candidate, AXS-02... (more)

Overall

Beta: 3.50
Market Cap(Mil.): $503.20
Shares Outstanding(Mil.): 33.28
Dividend: --
Yield (%): --

Financials

  AXSM.OQ Industry Sector
P/E (TTM): -- 109.48 62.40
EPS (TTM): -1.14 -- --
ROI: -221.68 7.96 11.78
ROE: -350.78 8.11 12.61

Earnings vs. Estimates